New active substance shows promise in treating acute sudden hearing loss

A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss. The latest results have been published in the scientific journal “Cell Death & Disease”.

Stroke deaths, despite advances in prevention, are set to near 10 million globally by 2050

The number of stroke deaths worldwide is set to climb 50% to nearly 10 million by 2050, with most cases occurring in low- and middle-income

October 9, 2023

New magnetoelectric material bridges gap in severed nerve, restores function

Researchers have long recognized the therapeutic potential of using magnetoelectrics ⎯ materials that can turn magnetic fields into electric fields ⎯ to stimulate neural tissue

October 11, 2023

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

HOUSTON — Patients with melanoma brain metastases had better survival if they received radiotherapy (RT) followed by immunotherapy instead of the reverse sequence, a meta-analysis

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.